A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects

NCT03527095 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: FDL169

Sponsor

Flatley Discovery Lab LLC